欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/3312/001
药品名称Aptiflow
活性成分
    • bimatoprost 0.1 mg/g
剂型Eye gel in single-dose container
上市许可持有人Laboratoires Thea Zone Industrielle Du Brezet, 12 Rue Louis Bleriot 63100 Clermont Ferrand, France
参考成员国 - 产品名称Denmark (DK)
Aptiflow
互认成员国 - 产品名称
    • Italy (IT)
    • Czechia (CZ)
      Aptiflow
    • Greece (GR)
    • Romania (RO)
    • Germany (DE)
      Aptiflow 0.1 mg/g Augengel im Einzeldosisbehältnis
    • Sweden (SE)
    • Slovakia (SK)
    • Belgium (BE)
      Elymbus 0,1 mg/g gel ophtalmique en récipient unidose
    • Norway (NO)
    • Slovenia (SI)
    • Netherlands (NL)
    • Finland (FI)
    • Croatia (HR)
    • Luxembourg (LU)
    • Poland (PL)
      Aptiflow
    • Iceland (IS)
    • Latvia (LV)
    • Ireland (IE)
    • Lithuania (LT)
      Elymbus 0,1mg/g akių gelis vienadozėje talpyklėje
    • Austria (AT)
    • Estonia (EE)
    • France (FR)
    • Hungary (HU)
    • Spain (ES)
    • Bulgaria (BG)
      Aptiflow
    • Portugal (PT)
    • Cyprus (CY)
      Aptiflow0,1 mg/g eye gel, in single-dose container
许可日期2023/05/25
最近更新日期2023/06/28
药物ATC编码
    • S01EE03 bimatoprost
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase